“…Compound 8b (16 mg, 0.053 mmol) was subject to coupling with UMP-morpholidate and purification as described for the preparation of 4a. This procedure yielded 4b as a white powder (8.6 mg, 26%): 1 H NMR (400 MHz, D2O) δ 7.93 (d, 1H, J ) 8.1), 5.99-5.98 (m, 2H), 5.60 (dd, 1H, J ) 7.3, 3.4), 4.37-4.17 (m, 5H), 4.13 (dq, 1H, J ) 6.7, 2.6), 3.93 (dd, 1H, J ) 10.2, 2.4), 3.75 (dd, 1H, J ) 9.6, 9.3), 3.52 (ddd, 1H, J ) 9.8, 3.3, 3.1), 3.39 (dd, 1H, J ) 10.1, 9.2), 1.21 (d, 3H, J ) 6.6); 13 C NMR (75 MHz, D2O) δ 166.6, 152.1, 141.8, 102.9, 95.8 (d, J ) 6.5), 88.6, 83.5 (d, J ) 8.9), 74.9, 74.0, 73.3, 71.8 (d, J ) 8.2), 70.8, 69.9, 66.8, 65.2 (d, J ) 5.0), 15.6; 31 P NMR (121.5 MHz, D2O) δ -10.8 (d, 1P, J ) 20.3), -12.5 (d, 1P, J ) 20.8); HR-LSI(-) MS (thioglycerol matrix) m/z calcd for C16H24N2O17P2Na 601.0448, found 601.0461. 6,7-Dideoxy-1,2:3,5-di-O-isopropylidene-6-C-methyl-r-D-gluco-hept-6-enofuranose (10).…”